Category: Upper Gastrointestinal Tract

Prognostic Value in Gastric Cancer Patients

The age-adjusted Charlson Comorbidity Index and sarcopenia are significant independent risk factors for prognosis in gastric cancer patients. A new prognostic score, ACCIS, combining these factors, accurately predicts prognosis and enhances predictive accuracy. Integration of ACCI score and sarcopenia improves prognostic predictions, leading to the development of a nomogram with a high concordance index for […]

Clinical Significance of C-Reactive Protein-Albumin-Lymphocyte Index in Gastric Cancer Patients

The preoperative C-reactive protein-albumin-lymphocyte (CAlly) index is an independent prognostic factor for overall and disease-free survival in patients with gastric cancer. It is also a valuable predictive marker for postoperative surgical site infection, highlighting its potential clinical significance in perioperative and oncologic management of gastric cancer patients. Journal Article by Okugawa Y, Ohi M (…) […]

Effectiveness of Laparoscopic Indocyanine Green Tracer-guided Lymphadenectomy for Locally Advanced Gastric Cancer

Indocyanine green (ICG) guidance significantly improves lymph node dissection quality in patients with locally advanced gastric cancer undergoing laparoscopic radical gastrectomy after neoadjuvant chemotherapy. ICG led to higher numbers of retrieved lymph nodes, reduced noncompliance rates, and improved lymphadenectomy quality for patients with complete response. Surgical outcomes were similar between ICG and non-ICG groups, suggesting […]

Optimal Management Strategy for Patients with Paraesophageal Hernia

Updated Markov model shows elective laparoscopic hernia repair increases life-years in individuals with paraesophageal hernia symptoms and Cameron lesions. Comorbid conditions impact life expectancy but do not change the preference for surgery over watchful waiting in most cases, except for the elderly without Cameron lesions. Individualized guidance for management of paraesophageal hernia patients can be […]

Comparison of D2 lymphadenectomy vs. D2 lymphadenectomy + complete mesogastric excision in gastric cancer

Adding complete mesogastric excision to D2 lymphadenectomy for gastric cancer improves 3-year disease-free survival without significant difference in overall survival rates. Recurrence rates were lower in the complete mesogastric excision group. This finding suggests potential benefits of the combined approach for better outcomes in advanced gastric cancer patients. Comparative Study by Xie D, Shen J […]

Diagnostic Role of Indocyanine Green in Gastric Cancer Surgery

In laparoscopic subtotal gastrectomy for gastric cancer, utilizing indocyanine green (ICG) fluorescence for lymph node dissection significantly enhances metastasis detection, with a sensitivity of 75.86% and a high negative predictive value of 97%. The method effectively visualizes lymph nodes, aiding in clinically radical gastrectomy, suggesting its potential as a valuable tool in gastric cancer surgery. […]

Predicting Anastomotic Leakage After Esophagectomy: Role of Early Inflammatory Biomarkers

Early postoperative CRP levels are a key predictor of anastomotic leakage after esophagectomy, with a cutoff value of < 222 mg/l on day 2 showing 81% sensitivity and 88% specificity. Other biomarkers like WBC counts and albumin levels had limited diagnostic accuracy. A NUN score >10 on day 4 was unreliable. CRP < 127 mg/l […]

Superior Clinical Outcomes of Esophagectomy in Elderly Esophageal Cancer Patients

In patients over 70 with esophageal squamous cell carcinoma (ESCC), surgical treatment yields better clinical outcomes compared to nonsurgical approaches. A retrospective study showed that the 3-year overall survival was 59% for the surgical group and 27% for the nonsurgical group. The median progression-free survival was also higher in the surgical group (38.3 months vs. […]

Improved Operative Outcomes in Gastroesophageal Junction Adenocarcinoma Resected Cases Over Time

A single-center study on resected gastroesophageal junction adenocarcinoma showed improved operative outcomes over time, with type I tumors linked to poorer survival. Most patients received neoadjuvant therapy and underwent minimally invasive surgery, resulting in low mortality rates and decreased morbidity. Signet ring tumors were more common in type III cases, influencing overall survival. Pathologic features […]

Utilizing Mediastinal Drains Alone After Esophageal Cancer Surgery

Utilizing mediastinal drains alone post-esophageal cancer surgery is safe and reduces postoperative pain. It can potentially replace closed thoracic drains, showing comparable results in terms of hyperthermia, leukocytes, drainage, hospitalization, and pulmonary complications. Early detection of abnormal drainage fluid is a significant benefit, with no increase in anastomotic leakage incidence or mortality rates. Journal Article […]